How much cash does Bio-Techne generate?

Bio-Techne (TECH) generated $294.9M in operating cash flow over the trailing twelve months.

What is Bio-Techne's free cash flow?

After $25.3M of capital expenditures, Bio-Techne's free cash flow was $269.6M over the trailing twelve months, up 22.1% year over year.

Where does Bio-Techne's cash flow data come from?

Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Bio-Techne TECH Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q3 '26	TTM Q2 '26	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25
Net income	——	——	——	——	$131.67M-16.7%
Depreciation and amortization	$100.33M-3.3%	$103.73M-2.2%	$106.11M-3.5%	$109.9M-0.9%	$110.85M+0.2%
Stock-based compensation	$40.69M-2.2%	$41.58M-1.8%	$42.33M+3.7%	$40.83M-5.8%	$43.35M+8.1%
Deferred income taxes	——	——	-$40.49M+20.8%	-$51.11M-80.1%	-$28.38M+7.1%
Change in inventories	——	$22.55M-23.6%	$29.51M+61.1%	$18.32M+12.2%	$16.33M-0.1%
Change in accounts payable	——	-$22.03M—	——	——	——
Change in accrued liabilities	——	——	$1.55M-89.9%	$15.41M-11.8%	$17.46M-16.1%
Other working capital changes	——	——	——	——	——
Change in prepaid expenses	——	$10.71M—	——	——	——
Change in income taxes payable/receivable	——	——	-$12.75M-251%	$8.47M+146%	-$18.51M-69.3%
Net gains (losses) on investments	——	——	——	——	——
Change in receivables	-$20.94M—	——	——	——	——
Net cash from operating activities	$294.86M+18.3%	$249.32M-0.8%	$251.25M-12.6%	$287.56M+8.6%	$264.85M-13.1%
Capital expenditures	$25.26M-3.9%	$26.3M-3.3%	$27.2M-12.3%	$31.01M-29.7%	$44.1M-12.5%
Proceeds from maturities/sales of investments	——	——	——	——	——
Purchases of equity securities	——	——	——	——	——
Net cash from investing activities	-$11.13M+21.5%	-$14.19M-6.7%	-$13.3M+62.6%	-$35.59M+19.8%	-$44.4M+14.6%
Dividends paid	$49.82M-0.1%	$49.88M-0.5%	$50.15M-0.5%	$50.39M-0.5%	$50.63M0.0%
Repurchases of common stock	——	——	——	——	——
Repayments of debt	$196M+36.1%	$144M+38.5%	$104M+35.1%	$77M-20.6%	$97M-34.0%
Proceeds from issuance of common stock	$64.42M+30.6%	$49.33M-1.6%	$50.13M-3.1%	$51.74M-24.4%	$68.45M-4.8%
Taxes paid for net share settlement	$10.88M-1.2%	$11.01M+2.2%	$10.77M+65.1%	$6.52M-2.5%	$6.69M+1.9%
Net cash from financing activities	-$226.36M+10.1%	-$251.69M+12.2%	-$286.54M-12.9%	-$253.91M-13.6%	-$223.55M-7.5%
Effect of exchange rate changes on cash	——	——	$5.6M-53.0%	$11.93M—	——
Net increase (decrease) in cash	$69.15M+1,581%	-$4.67M—	——	——	——
Interest paid	——	——	——	——	$16.34M+3.8%
Income taxes paid	——	——	——	——	——
Asset Impairment Restructuring Charge	——	——	——	$21.31M+69.2%	$12.6M+1.0%
Equity Method Investment, Realized Gain (Loss) on Disposal	$772K-16.3%	$922K+7.5%	$858K-8.5%	$938K+197%	-$968K+54.5%
Fair Value Write Up Of Acquired Inventory	——	——	——	$751K+2.5%	$733K-0.7%
Increase (Decrease) in Accounts and Other Receivables	-$20.94M—	——	——	——	——
Accrued compensation and employee benefits	——	——	$1.55M-89.9%	$15.41M-11.8%	$17.46M-16.1%
Increase (Decrease) in Prepaid Expense	——	$10.71M—	——	——	——
Noncash Portion Of Lease Expense	-$2.44M-53.5%	-$1.59M-136%	-$672K-198%	$685K+36.5%	$502K-55.5%
Recovery Of Assets Held For Sale	——	——	——	——	——
Payments to Acquire Equity Securities, FV-NI	——	——	——	——	——
Sale of investments	——	——	——	——	——
Proceeds From Sale Of Property Held For Sale	——	——	——	——	——
Proceeds Payments From Equity Method Investment Dividends Or Distributions Return Of Capital	——	——	——	$7.29M+1.0%	$7.22M+1.0%
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations	——	——	$5.6M-53.0%	$11.93M—	——
Proceeds From Long Term Lines Of Credit	——	——	——	——	——
Unrealized Gain (Loss) on Investments	——	——	——	——	——
Free cash flow	$269.6M+20.9%	$223.02M-0.5%	$224.06M-12.7%	$256.55M+16.2%	$220.76M-13.2%
Free cash flow	$269.6M+20.9%	$223.02M-0.5%	$224.06M-12.7%	$256.55M+16.2%	$220.76M-13.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bio-Techne.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Bio-Techne generate?: Bio-Techne (TECH) generated $294.9M in operating cash flow over the trailing twelve months.
What is Bio-Techne's free cash flow?: After $25.3M of capital expenditures, Bio-Techne's free cash flow was $269.6M over the trailing twelve months, up 22.1% year over year.
Where does Bio-Techne's cash flow data come from?: Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.